---
id: temporal-lobe-epilepsy-status
condition: Status Epilepticus - Temporal Lobe Origin
aliases: [temporal lobe status epilepticus, focal status epilepticus, complex partial status epilepticus, nonconvulsive status epilepticus temporal]
icd10: [G41.0, G41.1, G41.2, G40.219]
esi: 1
time_to_harm:
  irreversible_injury: "< 30 minutes"
  death: "< 2 hours"
  optimal_intervention_window: "< 5 minutes"
category: neurological
track: tier1
sources:
  - type: guideline
    ref: "Glauser T et al. Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults. AES Guideline Committee. Epilepsy Curr. 2016;16(1):48-61"
  - type: guideline
    ref: "Brophy GM et al. Guidelines for the Evaluation and Management of Status Epilepticus. Neurocrit Care. 2012;17(1):3-23"
  - type: guideline
    ref: "Trinka E et al. A definition and classification of status epilepticus. Report of the ILAE Task Force. Epilepsia. 2015;56(10):1515-1523"
last_updated: "2026-03-01"
compiled_by: agent
risk_tier: A
validation:
  automated_consistency_check: null
  dose_range_validator: null
  unit_normalization_check: null
  cross_file_consistency_check: null
  citation_presence_check: null
  duplicate_content_check: null
  outlier_detection_flag: clear
  schema_version: "2.0"
  provenance_links: []
---
# Status Epilepticus - Temporal Lobe Origin

## Recognition

**Definitions (ILAE 2015):**
- Status epilepticus: continuous seizure >= 5 minutes OR >= 2 seizures without return to baseline between
- Refractory SE: failure of adequate doses of 2 medications (benzodiazepine + second-line agent)
- Super-refractory SE: SE persisting >= 24 hours after onset of anesthetic therapy

**Temporal lobe SE presentations:**
- **Convulsive SE (generalized tonic-clonic from temporal focus):** bilateral convulsions, loss of consciousness, tongue biting, incontinence — overt and easily recognized
- **Focal SE with impaired awareness (formerly complex partial SE):** prolonged confusional state with automatisms (lip smacking, hand fumbling, repetitive movements), staring, unresponsiveness; easily mistaken for psychiatric illness, intoxication, or postictal state
- **Nonconvulsive SE (NCSE):** persistent altered mental status without overt motor activity; diagnosis requires EEG; up to 20% of comatose ICU patients in NCSE

**Key features of temporal lobe origin:**
- Aura (if reported): epigastric rising sensation, deja vu, fear, olfactory/gustatory hallucinations
- Oroalimentary automatisms (lip smacking, chewing)
- Ipsilateral hand automatisms with contralateral arm dystonic posturing
- Postictal aphasia if dominant hemisphere involved
- Secondary generalization common

**Common triggers/etiologies:**
- Antiepileptic drug non-adherence (most common in known epilepsy)
- Alcohol withdrawal
- Acute symptomatic: stroke, hemorrhage, CNS infection, traumatic brain injury, metabolic derangement
- Low-grade temporal lobe tumor (newly presenting SE)
- Anti-NMDA receptor encephalitis (young women; psychiatric symptoms)

## Critical Actions

| Phase | Time | Action |
|---|---|---|
| Stabilization | 0-5 min | ABCs, glucose check, IV access, O2 |
| First-line | 5-20 min | Benzodiazepine |
| Second-line | 20-40 min | Anti-seizure medication IV |
| Refractory | >40 min | Anesthetic agents, intubation |

1. **Check point-of-care glucose** — treat hypoglycemia with dextrose 50% 50 mL IV (adult) or D10 5 mL/kg (pediatric)
2. **Benzodiazepine immediately:** midazolam 10 mg IM (if no IV) OR lorazepam 4 mg IV (0.1 mg/kg, max 4 mg, may repeat x1 in 5 min) OR diazepam 10 mg IV
3. **Second-line AED if seizures persist after 2 doses of benzodiazepine:** fosphenytoin 20 mg PE/kg IV at 150 mg PE/min OR valproate 40 mg/kg IV over 10 min (max 3000 mg) OR levetiracetam 60 mg/kg IV over 15 min (max 4500 mg)
4. **Continuous EEG monitoring** — essential; NCSE cannot be diagnosed clinically
5. **Refractory SE (> 40 min):** intubate, initiate continuous infusion (midazolam, propofol, or pentobarbital)
6. **Identify and treat underlying cause** — CT head, LP, toxicology, metabolic panel

## Differential Diagnosis

- Psychogenic nonepileptic spells (PNES) (eyes closed, waxing-waning, pelvic thrusting, no postictal state; normal EEG)
- Prolonged postictal state (confusion resolving over 30-60 min; no ongoing seizure on EEG)
- Encephalitis (fever, CSF pleocytosis, MRI changes)
- Metabolic encephalopathy (hepatic, uremic, hyponatremia, hypoglycemia)
- Drug intoxication or withdrawal (toxicology screen positive)
- Syncope (brief, self-limited, no postictal confusion)
- Acute stroke (focal deficits, DWI restriction)
- Movement disorder (dyskinesia, dystonia — no EEG correlate)
- Serotonin syndrome (medication history, clonus, hyperthermia)

## Workup

- **Point-of-care glucose** — immediate
- **Continuous EEG** — gold standard for diagnosis and monitoring; bedside video-EEG preferred
- **CT head without contrast** — rule out hemorrhage, mass, hydrocephalus
- **BMP:** sodium, calcium, magnesium, glucose, BUN, creatinine
- **CBC, hepatic function panel**
- **Antiepileptic drug levels** (phenytoin, valproate, carbamazepine, levetiracetam)
- **Toxicology screen** (urine drug screen, alcohol level)
- **LP** — if CNS infection or autoimmune encephalitis suspected (after CT excludes mass effect)
- **MRI brain** — when stable; temporal lobe pathology (mesial temporal sclerosis, tumor, encephalitis)
- **Anti-NMDA receptor antibodies, LGI1, CASPR2** — if autoimmune encephalitis suspected

## Treatment

### Phase 1: Stabilization (0-5 Minutes)
- Airway positioning, suction, O2 by nasal cannula or NRB
- IV access x 2 (large-bore)
- Thiamine 100 mg IV + dextrose 50% 50 mL IV if glucose < 60 mg/dL
- Cardiac monitoring, pulse oximetry

### Phase 2: First-Line (5-20 Minutes)
- **Midazolam** 10 mg IM (preferred if no IV access; RAMPART trial) — single dose
- **Lorazepam** 0.1 mg/kg IV (max 4 mg per dose) — repeat once at 5 min if needed
- **Diazepam** 0.15-0.2 mg/kg IV (max 10 mg per dose) — repeat once at 5 min

### Phase 3: Second-Line (20-40 Minutes)
- **Fosphenytoin** 20 mg PE/kg IV at 150 mg PE/min — cardiac monitoring; avoid in known allergy
- **Valproate** 40 mg/kg IV over 10 min (max 3000 mg) — preferred in generalized epilepsy; avoid in hepatic failure, pregnancy, mitochondrial disease
- **Levetiracetam** 60 mg/kg IV over 15 min (max 4500 mg) — fewest drug interactions; no cardiac monitoring needed
- **Phenobarbital** 20 mg/kg IV at 50-100 mg/min — if above unavailable; respiratory depression risk

### Phase 4: Refractory SE (> 40 Minutes)
- **Intubation** (RSI with propofol or ketamine; avoid succinylcholine if prolonged convulsions — hyperkalemia risk)
- **Midazolam** 0.2 mg/kg IV bolus, then 0.05-2 mg/kg/hr infusion — titrate to EEG burst suppression
- **Propofol** 1-2 mg/kg IV bolus, then 20-65 mcg/kg/min infusion — monitor for propofol infusion syndrome (> 48h, > 80 mcg/kg/min)
- **Pentobarbital** 5-15 mg/kg IV bolus, then 0.5-5 mg/kg/hr — for super-refractory SE; significant hypotension

### Phase 5: Super-Refractory SE (> 24 Hours)
- Ketamine 1-3 mg/kg IV bolus, then 1-10 mg/kg/hr infusion
- Consider immunotherapy (IVIG, steroids, PLEX) if autoimmune etiology
- Hypothermia protocol (32-35C) — emerging evidence
- Neurosurgery consultation for resective surgery if focal lesion identified

## Disposition

- **All SE patients:** ICU admission with continuous EEG monitoring
- **Refractory SE:** neuro-ICU, mechanical ventilation, continuous infusion titrated to EEG
- **Single seizure terminating with benzodiazepine, returned to baseline:** ED observation 4-6 hours, may discharge with neurology follow-up if known epilepsy and medication non-adherence identified
- **New-onset SE:** mandatory admission for workup (MRI, EEG, LP)
- **Transfer:** any facility without continuous EEG monitoring should transfer refractory SE to a comprehensive epilepsy center

## Pitfalls

1. **Underdosing benzodiazepines.** Subtherapeutic dosing is the most common error. Lorazepam must be dosed at 0.1 mg/kg (4 mg for a 40 kg patient, 8 mg for an 80 kg patient — not a flat 2 mg for everyone).

2. **Missing nonconvulsive status epilepticus.** Up to 20% of comatose ICU patients are in NCSE. Any unexplained altered mental status, especially in a known epileptic, requires EEG. Clinical exam alone cannot diagnose NCSE.

3. **Attributing focal SE to psychiatric illness.** Temporal lobe SE with automatisms and confusion is frequently misdiagnosed as psychogenic nonepileptic spells, intoxication, or psychiatric crisis. EEG is the only way to differentiate.

4. **Not checking antiepileptic drug levels.** Medication non-adherence is the most common trigger for SE in known epileptics. Subtherapeutic levels guide immediate treatment decisions.

5. **Delaying second-line treatment.** If seizures persist after two adequate doses of benzodiazepines, immediately proceed to second-line agents. Waiting prolongs SE and worsens outcomes. After 30 minutes of SE, neuronal injury begins.

6. **Forgetting glucose and thiamine.** Hypoglycemic seizures look identical to epileptic seizures. A fingerstick glucose takes seconds and can prevent unnecessary escalation of care.
